J. Mark Hattendorf
Geen lopende functies
Profiel
J.
Mark Hattendorf has been a Director of CryoCor, Inc. since July 2006.
From April 2005 to October 2006, he was Chief Financial Officer of EWI Holdings and worked at Peat Marwick Mitchell & Co. Mr. Hattendorf is a Certified Public Accountant and received an undergraduate degree in Accounting and an MBA in Finance from Loyola Marymount University.
Eerdere bekende functies van J. Mark Hattendorf
| Bedrijven | Functie | Einde |
|---|---|---|
CryoCor, Inc.
 CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Directeur/Bestuurslid | 28-05-2008 |
EWI Holdings, Inc.
 EWI Holdings, Inc. Data Processing ServicesTechnology Services EWI Holdings, Inc. provides payment processing services. The company was founded by Miles Paschini in 1999 and is headquartered in San Diego, CA. | Financieel Directeur/CFO | - |
Opleiding van J. Mark Hattendorf
| Loyola Marymount University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
EWI Holdings, Inc.
EWI Holdings, Inc. Data Processing ServicesTechnology Services EWI Holdings, Inc. provides payment processing services. The company was founded by Miles Paschini in 1999 and is headquartered in San Diego, CA. | Technology Services |
CryoCor, Inc.
CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Health Technology |
